VIVUS (VVUS) Reports In-Line Q4 EPS

Go back to VIVUS (VVUS) Reports In-Line Q4 EPS

Vivus (VVUS) Q4 Qsymia Sales Meet Expectations, Needham & Company Notes

February 25, 2015 8:51 AM EST

Needham & Company analyst Alan Carr reiterated a Hold rating on Vivus (NASDAQ: VVUS) following Q4 results. The analyst noted Qsymia sales meet expectations.

Carr commented, "Vivus reported $12.7M in U.S. Qsymia sales, in line with our $13.0M estimate. Total Stendra/Spendra... More